Akebia Therapeutics, Inc. (AKBA)

Akebia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	39.5	42.93	90.47	149.8	228.7	147.45
Short-Term Investments	-	-	-	-	39.99	0.25
Cash & Short-Term Investments	39.5	42.93	90.47	149.8	268.69	147.69
Cash Growth	-26.27%	-52.55%	-39.61%	-44.25%	81.92%	-54.08%
Accounts Receivable	29.77	39.29	40.28	55.89	28.58	38.86
Receivables	29.77	39.29	40.28	55.89	28.58	38.86
Inventory	23.87	15.69	21.57	36.63	61.02	116.35
Prepaid Expenses	11.63	14.49	15.62	28.83	12.76	6.36
Restricted Cash	-	-	-	-	0.4	0.26
Other Current Assets	7.33	5.75	17.25	-	-	-
Total Current Assets	112.1	118.15	185.18	271.15	371.44	309.53
Property, Plant & Equipment	13.26	16.05	34.37	40.61	35.5	39.42
Goodwill	59.04	59.04	59.04	59.04	55.05	55.05
Other Intangible Assets	18.02	36.04	72.08	108.13	144.17	291.21
Other Long-Term Assets	17.78	12.42	5.37	50.42	37.98	75.99
Total Assets	220.2	241.7	356.05	529.35	644.14	771.2
Accounts Payable	10.11	14.64	18.02	33.59	41.31	39.22
Accrued Expenses	27.23	42.94	53.92	97.51	125.34	124.08
Current Portion of Long-Term Debt	2.01	19.55	32	97.54	-	-
Current Portion of Leases	5.18	4.49	4.74	4.8	5.29	4.99
Current Unearned Revenue	43.3	-	3.74	20.91	15.21	39.83
Other Current Liabilities	19.47	18.26	17.12	6.7	-	-
Total Current Liabilities	107.3	99.87	129.54	261.05	187.15	208.12
Long-Term Debt	91.13	71.2	91.56	53.08	96.38	75.81
Long-Term Leases	6.3	8.95	28.96	33.7	24.62	27.53
Long-Term Unearned Revenue	-	43.3	43.3	21.47	25.35	33.12
Other Long-Term Liabilities	49.22	48.98	57.47	86.03	63.03	31.87
Total Liabilities	253.95	272.29	350.82	455.34	396.52	376.44
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,602	1,578	1,562	1,537	1,425	1,189
Retained Earnings	-1,636	-1,609	-1,557	-1,463	-1,178	-794.05
Comprehensive Income & Other	0.01	0.01	0.01	0.01	0.01	-
Total Common Equity	-33.75	-30.58	5.23	74.01	247.62	394.76
Shareholders' Equity	-33.75	-30.58	5.23	74.01	247.62	394.76
Total Liabilities & Equity	220.2	241.7	356.05	529.35	644.14	771.2
Total Debt	104.62	104.18	157.27	189.13	126.29	108.32
Net Cash (Debt)	-65.12	-61.26	-66.8	-39.33	142.41	39.37
Net Cash Growth	-	-	-	-	261.69%	-87.16%
Net Cash Per Share	-0.33	-0.33	-0.37	-0.24	1.03	0.33
Filing Date Shares Outstanding	210.29	209.37	184.25	181.23	153.5	129.86
Total Common Shares Outstanding	209.93	194.58	184.14	177	148.07	121.67
Working Capital	4.8	18.28	55.65	10.1	184.29	101.42
Book Value Per Share	-0.16	-0.16	0.03	0.42	1.67	3.24
Tangible Book Value	-110.82	-125.67	-125.9	-93.16	48.4	48.49
Tangible Book Value Per Share	-0.53	-0.65	-0.68	-0.53	0.33	0.40
Machinery	-	-	-	5.85	5.79	5.55
Leasehold Improvements	-	-	-	8.57	8.57	8.5

Source: S&P Capital IQ. Standard template. Financial Sources.